首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1375150

南美洲和中美洲結直腸癌診斷市場預測至 2028 年 - COVID-19 影響和區域分析 - 按模式和最終用戶（醫院、診斷實驗室、癌症研究機構等）

South & Central America Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

出版日期: 2023年08月28日 | 出版商:

The Insight Partners | 英文 131 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023年，南美洲和中美洲結直腸癌診斷市場價值為7.4913億美元，預計到2028年將達到10.8786億美元。預計2023年至2028年的年複合成長率為7.7%。

大腸鏡檢查中的人工智慧推動南美洲和中美洲結直腸癌診斷市場

胃腸病學中結直腸癌 (CRC) 的早期檢測為患者提供了無疾病生存和整體生存的最佳機會。然而，大腸鏡檢查結果顯示病變檢測有顯著差異。腺瘤檢出率（ADR）是評估內視鏡醫師進行大腸直腸癌篩檢的大腸鏡檢查品質的黃金標準。

利用人工智慧技術診斷和治療多種癌症，尤其是大腸癌，目前正受到廣泛關注。各種人工智慧支援系統可用於個人化和新穎的大腸直腸癌治療策略。在內視鏡檢查中，人工智慧廣泛涉及電腦視覺技術，允許電腦「看到」並解釋視覺內容。透過機器學習過程和深度學習，可以訓練人工智慧系統透過將黃金標準與合適的圖像聯繫起來來識別「正常」特徵。使用電腦視覺進行病變檢測將是人工智慧在胃腸病學中的首次應用。它將有助於提高結腸鏡檢查中發現和識別息肉的內視鏡檢查實踐的品質。

儘管大腸鏡檢查中的人工智慧是一個廣泛的新領域，但它可以潛在地提高內視鏡檢查和患者護理的品質。它還可以改變大腸鏡檢查的管理績效和品質改進的過程，同時改善幾個關鍵績效指標。美敦力 (Medtronic) 在印度推出了人工智慧驅動的 GI Genius 大腸鏡檢查模組。這種依賴深度學習演算法和即時資料的變革性解決方案使醫生能夠透過在結腸鏡檢查過程中提供增強的可視化來檢測和治療大腸直腸癌。 GI Genius 等人工智慧應用可以改善 ADR，促進結直腸癌的早期檢測、更好的病變臨床管理以及組織的詳細表徵。因此，採用人工智慧進行大腸直腸癌成像測試可能會在未來幾年為南美洲和中美洲結直腸癌診斷市場帶來新趨勢。

南美洲和中美洲大腸癌診斷市場概述

南美洲和中美洲大腸直腸癌診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。據巴西衛生部稱，由於農作物使用殺蟲劑，結腸癌病例顯著增加。食用此類食物和水會導致結腸癌的發生。此外，老年人中結直腸癌的盛行率較高。根據 Globocan 2020資料，2020 年巴西新增約 55,102 例大腸直腸癌病例。此外，男性病例為 27,346 例，女性病例為 27,756 例。巴西各地，特別是私營部門，開展了有關大腸癌的宣傳活動。巴西腸癌預防協會 (ABRAPRECI) 和大腸癌預防和篩檢計畫已經啟動。宣傳活動和篩檢計畫的成長增加了對大腸鏡檢查服務的需求。此外，2020年12月，法國診斷公司HalioDx與Diagnostics da America (DASA)簽署協議，在巴西分銷其Immunoscore結腸癌風險評估測試。免疫評分透過測量腫瘤部位的宿主免疫反應來幫助預測早期結腸癌復發的風險，這有助於規劃治療策略。根據協議條款，位於巴西聖保羅的 DASA 擁有該測試的獨家經銷權，透過 40 個實驗室網路提供該測試。由於上述因素，巴西南美洲和中美洲大腸直腸癌診斷市場在預測期內可能會出現利潤豐厚的機會。

南美洲和中美洲大腸癌診斷市場收入及 2028 年預測（百萬美元）

南美洲和中美洲大腸癌診斷市場細分

南美洲和中美洲大腸直腸癌診斷市場分為模式、最終用戶和國家。

根據模式，南美洲和中美洲大腸直腸癌診斷市場分為影像學檢查和糞便測試。 2023年，影像測試領域在南美洲和中美洲結直腸癌診斷市場中佔據更大佔有率。影像測試市場進一步細分為大腸鏡檢查、CT結腸造影、軟性乙狀結腸鏡檢查、膠囊內視鏡檢查等。基於糞便的檢測市場細分為糞便免疫化學測試（fit）、基於癒創木脂的糞便潛血測試（gfobt）和糞便DNA測試。

根據最終用戶，南美洲和中美洲大腸直腸癌診斷市場分為醫院、診斷實驗室、癌症研究機構等。 2023年，醫院細分市場在南美洲和中美洲結直腸癌診斷市場中佔據最大佔有率。

根據國家/地區，南美洲和中美洲結直腸癌診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2023年，巴西佔據南美洲和中美洲結直腸癌診斷市場的最大佔有率。

Medtronic Plc、Illumina Inc、F. Hoffmann-La Roche Ltd、Quest Diagnostics Inc、Siemens Healthineers AG、Bruker Corp.；和 Eiken Chemical Co., Ltd. 是南美洲和中美洲結直腸癌診斷市場的領先公司。

The early detection of colorectal cancer (CRC) in gastroenterology offers patients the best opportunity for disease-free and overall survival. However, colonoscopy results show significant variations in lesion detection. The adenoma detection rate (ADR) is the gold standard for evaluating the quality of colonoscopy performed by endoscopists for colorectal cancer screening.

The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to "see" and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize "normal" characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.

Although AI in colonoscopy is a new field with an extended scope, it can potentially improve the quality of endoscopic examinations and patient care. It can also transform the process of managing performance and quality betterment in colonoscopy, alongside improving several key performance measures. Medtronic has launched its AI-powered GI Genius module for colonoscopy in India. This transformative solution that leans on deep learning algorithms and real-time data empowers physicians to detect and treat colorectal cancer by offering enhanced visualization during colonoscopy. AI applications such as the GI Genius can lead to an improved ADR, facilitating the earlier detection of colorectal cancer, better clinical management of lesions, and detailed characterization of tissues. Thus, the adoption of AI for colorectal cancer imaging tests is likely to bring new trends in the South & Central America colorectal cancer diagnostics market in the coming years.

South & Central America Colorectal Cancer Diagnostics Market Overview

The South & Central America colorectal cancer diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. According to the Brazilian Ministry of Health, cases of colon cancer have increased significantly due to the pesticides applied to the crops. Consumption of such food and water can lead to the development of colon cancer. In addition, the prevalence of colorectal cancer is higher among older adults. In 2020, around 55,102 new colorectal cancer cases were recorded in Brazil, as per Globocan 2020 data. In addition, 27,346 cases were reported in males and 27,756 in females. Awareness campaigns regarding colorectal cancer have grown across Brazil, especially from the private sector. The Brazilian Association of Intestinal Cancer Prevention (ABRAPRECI) and the Colorectal Cancer Prevention and Screening Program have been initiated. The growth in awareness campaigns and screening programs has increased the demand for colonoscopy services. In addition, in December 2020, a French diagnostic firm HalioDx signed an agreement with Diagnosticos da America (DASA) to distribute its Immunoscore colon cancer risk-assessment test in Brazil. Immunoscore assists in predicting the risk of relapse in early-stage colon cancer by measuring host immune responses at tumor sites, which helps plan treatment strategies. Under the agreement terms, in Brazil, Sao Paulo-based DASA has exclusive distribution rights to the test, offering it through 40 laboratory networks. Owing to the above-mentioned factors, the South & Central America colorectal cancer diagnostics market in Brazil is likely to witness lucrative opportunities during the forecast period.

South & Central America Colorectal Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Colorectal Cancer Diagnostics Market Segmentation

The South & Central America colorectal cancer diagnostics market is segmented into modality, end user, and country.

Based on modality, the South & Central America colorectal cancer diagnostics market is bifurcated into imaging tests and stool-based tests. In 2023, the imaging tests segment held a larger share of the South & Central America colorectal cancer diagnostics market. The market for the imaging tests segment is further segmented into colonoscopy, ct colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gfobt), and stool DNA test.

Based on end user, the South & Central America colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2023, the hospitals segment held the largest share of the South & Central America colorectal cancer diagnostics market.

Based on country, the South & Central America colorectal cancer diagnostics market is segmented into Brazil, Argentina, and Rest of South & Central America. In 2023, Brazil accounted for the largest share of the South & Central America colorectal cancer diagnostics market.

Medtronic Plc, Illumina Inc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, Bruker Corp.; and Eiken Chemical Co., Ltd. are the leading companies operating in the South & Central America colorectal cancer diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America colorectal cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America colorectal cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the colorectal cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Colorectal Cancer Diagnostics Market - by Modality
- 1.3.2 South & Central America Colorectal Cancer Diagnostics Market - by End User
- 1.3.3 South & Central America Colorectal Cancer Diagnostics Market - by Country

2. South & Central America Colorectal Cancer Diagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Colorectal Cancer Diagnostics Market - Market Landscape

4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert's Opinion

5. South & Central America Colorectal Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Colorectal Cancer
- 5.1.2 Launches of New Products
5.2 Key Restraints
- 5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Future Trends
- 5.3.1 Artificial Intelligence in Colonoscopy
5.4 Impact Analysis

6. Colorectal Cancer Diagnostics Market - South & Central America Analysis

6.1 South & Central America Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis

7. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - by Modality

7.1 Overview
7.2 South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
- 7.3.1 Overview
- 7.3.2 Stool Based Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Faecal Immunochemical Test (FIT)
  - 7.3.3.1 Overview
  - 7.3.3.2 Faecal Immunochemical Test (FIT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
  - 7.3.4.1 Overview
  - 7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Stool DNA Test
  - 7.3.5.1 Overview
  - 7.3.5.2 Stool DNA Test: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
- 7.4.1 Overview
- 7.4.2 Imaging Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Colonoscopy
  - 7.4.3.1 Overview
  - 7.4.3.2 Colonoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 CT Colonography
  - 7.4.4.1 Overview
  - 7.4.4.2 CT Colonography: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Flexible Sigmoidoscopy
  - 7.4.5.1 Overview
  - 7.4.5.2 Flexible Sigmoidoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.6 Capsule Endoscopy
  - 7.4.6.1 Overview
  - 7.4.6.2 Capsule Endoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.7 Others
  - 7.4.7.1 Overview
  - 7.4.7.2 Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - by End User

8.1 Overview
8.2 South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
- 8.4.1 Overview
- 8.4.2 Diagnostic Laboratories: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
- 8.5.1 Overview
- 8.5.2 Cancer Research Institutes: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - Country Analysis

9.1 Overview
- 9.1.1 South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
  - 9.1.1.1 Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.3 Brazil: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
    - 9.1.1.1.3.1 Brazil: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.1.3.2 Brazil: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.1.4 Brazil: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)
  - 9.1.1.2 Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.3 Argentina: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
    - 9.1.1.2.3.1 Argentina: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.2.3.2 Argentina: Colorectal Cancer Diagnostics Market, For Stool-Based Tests, 2020-2028 (US$ Million)
    - 9.1.1.2.4 Argentina: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)
  - 9.1.1.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
    - 9.1.1.3.3.1 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.3.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.3.4 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)

10. South & Central America Colorectal Cancer Diagnostics Market-Industry Landscape

10.1 Overview
10.2 Inorganic Growth Strategies
- 10.2.1 Overview
10.3 Organic Growth Strategies
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Illumina Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Quest Diagnostics Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Siemens Healthineers AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Bruker Corp
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Eiken Chemical Co., Ltd.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. South & Central America Colorectal Cancer Diagnostics Market -Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of South & Central America Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South & Central America Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Recent Inorganic Growth Strategies in the South & Central America colorectal cancer diagnostics market
Table 15. Recent Organic Growth Strategies in the South & Central America colorectal cancer diagnostics market
Table 16. Glossary of Terms

List Of Figures

Figure 1. South & Central America Colorectal Cancer Diagnostics Market Segmentation
Figure 2. South & Central America Colorectal Cancer Diagnostics Market, by Country
Figure 3. South & Central America Colorectal Cancer Diagnostics Market Overview
Figure 4. Imaging Tests Segment Held Largest Share of Modality Segment in South & Central America Colorectal Cancer Diagnostics Market
Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
Figure 6. South and Central America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. South & Central America Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. South & Central America Colorectal Cancer Diagnostics Market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 11. Stool Based Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Faecal Immunochemical Test (FIT): South & Central Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Guaiac-based Faecal Occult Blood Test (gFOBT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Stool DNA Test: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Imaging Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Colonoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. CT Colonography: South & Central American Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Flexible Sigmoidoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Capsule Endoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
Figure 22. Hospitals: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Diagnostic Laboratories: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cancer Research Institutes: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. South & Central America: Colorectal Cancer Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
Figure 28. Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)